Pr Lorenzo Drago will give a presentation about Lactobacillus salivarius LS01 and Bifidobacterium breve BR03 combination in Atopic Dermatitis: which evidences?

During the 3rd World COngress on Targeting Microbiota 2015 scheduled on October 21-23, 2015 at Institut Pasteur, Paris, the Scientific Committee is pleased to welcoming Pr Lorenzo Drago, from University of Milano, Italy who will give a talk about Lactobacillus salivarius LS01 and Bifidobacterium breve BR03 combination in Atopic Dermatitis: which evidences?

According Pr Drago: "Recently, our group showed a good clinical efficacy and an improvement in the cytokine expression profile after treatment with L.salivarius LS01 in adult and pediatric patients suffering of moderate/severe AD.

Additional in vivo and in vitro studies have demonstrated that L.salivarius LS01 additioned to Bifidobacterium breve BR03 can have a positive clinical effects as well as an improvement of the intestinal balance with a decreasing of Staphylococci load and a reduced intestinal permeability.

In a very recent in vitro study this combination showed promising probiotic properties and beneficial immunomodulatory activity that are increased respect to the strains tested alone."

If you would like to know more about Pr Drago's study, don't hesitate and come.

For more information: www.microbiota-site.com